Direct-to-patient biospecimen and health data collection
Official title: Joined Bio - JB-MR-250225, Direct to Patient Minimal Risk Research
Run by Joined Bio · NCT07128966 · Data updated 2026-11-12
This project collects biospecimens, health and lifestyle information from adults (including healthy volunteers and people with conditions like lupus, celiac disease, or chronic kidney disease) to connect them with researchers.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 90 Years |
| Sex | All |
| Enrollment | 100000 (estimated) |
| Sponsor | Joined Bio Industry-sponsored |
| Locations | 1 site (Lexington, Massachusetts) |
| Status | Recruiting |
| Started | April 1, 2025 |
| Main results expected | September 1, 2035 |
| Study ends | September 1, 2036 |
| Registry record updated | May 5, 2026 |
| Trial ID | NCT07128966 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged roughly 18–90 who can provide informed consent, are willing to provide requested biospecimens and data, and meet specific requested health profiles (including healthy controls or diagnoses of interest).
✕Probably not a fit
People seeking direct therapeutic benefit, children, prisoners, or anyone unable to provide the requested specimens or consent are unlikely to gain medical benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Joined Bio enrolls consenting adults and collects de-identified health information, lifestyle surveys, and minimal-risk biospecimens for use by qualified research partners. Participation is remote-friendly and focused on matching people with specific health profiles to research requests rather than providing medical treatment. Collected samples and data are linked to researcher queries to accelerate development of diagnostics and therapies. The program also includes optional interviews and surveys to contribute additional patient-centered data.
Why it matters
Potential benefit: If successful, this program could speed development of new tests and treatments by giving researchers access to diverse biospecimens and de-identified health data.
How similar studies have gone: Participant-driven biobanks and registries (for example, All of Us and UK Biobank) have demonstrated that centralized biospecimen and data collection can meaningfully advance research, so this approach is established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male or female, that are adults \[have reached the Age of Majority = aged 18 to 90 in most US states; aged 19-90 in Alabama or Nebraska; aged 21-90 in Mississippi or Puerto Rico\]. * Have reviewed and signed a consent or e-consent form for this study. If a person with diminished decision-making capacity, their Legally Authorized Representative has reviewed and signed the consent for on their behalf. * Be willing to comply with all study procedures and be available for the duration of the study. * Meets requirements of a current request for research participation (e.g. has previous diagnosis of a medical condition of interest or laboratory results within a specific range). * Pregnant women may be enrolled in this study in accordance with 45 CFR Part 46 Subpart B. Exclusion Criteria: * Unable to meet the Inclusion Criteria listed above. * Prisoners or children * Unable to provide the requested biospecimen(s), data or feedback without placing the individual at risk.
Where it's running
-
Joined Bio
Lexington, Massachusetts, United States Recruiting
Study contacts
- Principal investigator: Chris Ianelli, MD — Joined Bio
- Study coordinator: Emily L Hubbard, BS Biology
- Email: ehubbard@joined.bio
- Phone: 12567970003
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pedal Pump Device for Lower Extremity Edema in Hospitalized Patients
This study tests a foot-pump device to see if it is tolerable and can help reduce swelling in the legs of hospitalized patients with edema.
-
Adapting and testing PEN-Plus in Zambian primary care
Aiming to see if the PEN-Plus package can be adapted and used in two Zambian hospitals to better manage chronic diseases like heart disease, diabetes, hypertension, and sickle cell in primary care.
-
Effects of general vs spinal-epidural anesthesia on kidney transplant biomarkers
This study tests whether sevoflurane general anesthesia or combined spinal-epidural anesthesia changes markers of cellular stress and protective peptides in adults undergoing kidney transplantation.
-
Impact of a Clinical Information System on hospital outcomes for adults with chronic diseases
This study tests whether implementing a Clinical Information System helps reduce readmissions or death within 30 days after hospital discharge for adults with chronic conditions in Alberta.
-
Understanding subtypes of chronic musculoskeletal pain in youth
This observational study tests whether distinct brain and immune profiles can explain chronic musculoskeletal pain in teens and young adults to guide more precise treatments.
-
GSK4771261 in Healthy Adults Aged 25–55 in Asia and Europe
This study tests whether GSK4771261 is safe and how it behaves in the body of healthy adults to see if it could be used safely in the future.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.